BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22781105)

  • 1. The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats.
    Prahalathan P; Saravanakumar M; Raja B
    Redox Rep; 2012; 17(4):167-75. PubMed ID: 22781105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study.
    Prahalathan P; Kumar S; Raja B
    Asian Pac J Trop Biomed; 2012 Jun; 2(6):443-8. PubMed ID: 23569947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperlipidemic effect of Melothria maderaspatana leaf extracts on DOCA-salt induced hypertensive rats.
    Veeramani C; Al-Numair KS; Chandramohan G; Alsaif MA; Pugalendi KV
    Asian Pac J Trop Med; 2012 Jun; 5(6):434-9. PubMed ID: 22575974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of the essential oil of Alpinia zerumbet and its main constituent, terpinen-4-ol, in DOCA-salt hypertensive conscious rats.
    Lahlou S; Interaminense LF; Leal-Cardoso JH; Duarte GP
    Fundam Clin Pharmacol; 2003 Jun; 17(3):323-30. PubMed ID: 12803571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
    Kubacka M; Zadrożna M; Nowak B; Kotańska M; Filipek B; Waszkielewicz AM; Marona H; Mogilski S
    Hypertens Res; 2019 Aug; 42(8):1125-1141. PubMed ID: 30872813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of veratric acid on the cardiovascular risk of L-NAME-induced hypertensive rats.
    Saravanakumar M; Raja B
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):553-62. PubMed ID: 22361750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of the essential oil of Mentha x villosa in DOCA-salt-hypertensive rats.
    Lahlou S; Carneiro-Leão RF; Leal-Cardoso JH
    Phytomedicine; 2002 Dec; 9(8):715-20. PubMed ID: 12587691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.
    Borde P; Mohan M; Kasture S
    Nat Prod Res; 2011 Sep; 25(16):1549-59. PubMed ID: 21391110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of sesamol on DOCA-salt-induced oxidative stress in uninephrectomized hypertensive rats.
    Hemalatha G; Pugalendi KV; Saravanan R
    Mol Cell Biochem; 2013 Jul; 379(1-2):255-65. PubMed ID: 23576423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
    Park CG; Leenen FH
    J Korean Med Sci; 2001 Oct; 16(5):553-7. PubMed ID: 11641522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
    Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
    Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats.
    Galisteo M; García-Saura MF; Jiménez R; Villar IC; Zarzuelo A; Vargas F; Duarte J
    Mol Cell Biochem; 2004 Apr; 259(1-2):91-9. PubMed ID: 15124912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
    Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
    J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.